From: Favorable outcome in PLA2R positive HBV-associated membranous nephropathy
HBV-MN | Idiopathic MN | P value | |
---|---|---|---|
Glomerular lesions | |||
Sclerotic glomeruli, n (%) | 3/7 (42.9) | 37/69 (53.6) | 0.702 |
Segmental sclerosis, n (%) | 1/7 (14.3) | 8/67 (11.9) | 1.000 |
Mesangial proliferation, n (%) | 7/7 (100.0) | 56/69 (81.2) | 0.596 |
Immunofluorescence | |||
IgG, n (%) | 7/7 (100) | 69/69 (100) | |
C3, n (%) | 6/7 (85.7) | 65/69 (94.2) | 0.392 |
IgA, n (%) | 2/7 (28.6) | 8/69 (11.6) | 0.228 |
IgM, n (%) | 3/7 (42.9) | 12/68 (17.6) | 0.138 |
C1q, n (%) | 0/7 (0.0) | 7/69 (10.1) | 1.000 |
HBsAg, n (%) | 6/7 (85.8) | - | |
HBcAg, n (%) | 3/7 (42.9) | - | |
Electronic microscopy | |||
Subepithelial deposits, n (%) | 7/7 (100.0) | 46/46 (100.0) | |
Mesangial deposits, n (%) | 5/7 (71.4) | 7/46 (15.2) | 0.004 |